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Objective: To investigate the effect of anisodamine combining with conventional ther-
apy on the degree of lung injury and inﬂammatory reaction of patients with acute pul-
monary contusion.
Methods: A total of 48 patients with acute pulmonary contusion treated in our hospital
emergency department from April 2011 to October 2015 were enrolled as the research
object and were divided into experimental group and control group by using a method of
random number table. Experimental group received anisodamine combining with con-
ventional therapy and control group received conventional therapy. In the process of the
treatment, the mechanical ventilation time, hospital stays in intensive care unit and the
number of cases developed into acute respiratory distress syndrome and multiple organ
dysfunction syndromes of patients in two groups were observed. Oxygenation indexes of
patients were respectively calculated on Days 1, 2 and 3 after treatment. The contents of
inﬂammatory mediators in serum were detected on Day 3 after treatment.
Results: The mechanical ventilation time and hospital stays in intensive care unit
[(9.52 ± 1.41) vs. (14.57 ± 2.51) days] of patients in experimental group were signiﬁ-
cantly shorter than those in control group, and the number of cases developed into acute
respiratory distress syndrome [1 (4.17%) vs. 9 (37.50%)] and multiple organ dysfunction
syndrome [1 (4.17%) vs. 7 (29.17%)] was signiﬁcantly less than those in control group.
Oxygenation indexes (294.52 ± 41.26 vs. 257.63 ± 38.52; 357.74 ± 47.74 vs.
279.87 ± 31.46; 396.71 ± 55.12 vs. 279.87 ± 31.46) of patients were respectively
calculated on Days 1, 2 and 3 after treatment, which were signiﬁcantly higher than those
in the control group. On Day 3 after treatment, the contents of serum C-reactive protein
[(7.94 ± 1.05) vs. (14.49 ± 2.97) mg/L], tumor necrosis factor a [(264.69 ± 41.58) vs.
(417.87 ± 64.51) ng/L], interleukin-6 (IL-6) [(147.72 ± 21.36) vs. (257.68 ± 41.54) ng/L],
IL-8 [(93.68 ± 12.52) vs. (145.62 ± 22.65) ng/L], IL-10 [(205.64 ± 31.56) vs.
(336.62 ± 51.38) ng/L] and myeloid cells-1 (73.32 ± 10.39 vs. 114.45 ± 18.51) of patients
in experimental group were signiﬁcantly lower than those in the control group.
Conclusions: The anisodamine combining with conventional therapy can relieve the
degree of lung injury caused by acute pulmonary contusion, improve ventilatory function,
lower the incidence of acute respiratory distress syndrome and multiple organ dysfunction
syndrome and inhibit the activation of inﬂammatory reaction and the release of inﬂam-
matory mediators.1. Introduction
Among the emergency trauma patients, more than one-
third of patients have blunt chest injury, while pulmonary
contusion is the most common complications after blunt chest
injury[1,2]. Pulmonary contusion can increase the risk of the
incidence of acute respiratory distress syndrome (ARDS)
and meanwhile, severe patients need to be assisted breathing
with ventilator, which can increase the incidence of
ventilator-associated pneumonia. In the pathogenic processCC BY-NC-ND license (http://
Table 1
The general data of patients in the two groups.
General data Experimental
group (n = 24)
Control
group (n = 24)
Gender (male/female) 17/7 16/8
Age (years) 38.5 ± 5.9 37.1 ± 4.4
BMI (kg/m2) 22.19 ± 3.14 22.68 ± 2.95
Respiratory frequency
(times/min)
26.52 ± 3.12 26.18 ± 3.32
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lung injury occurs the earliest and has the highest incidence,
which runs through each pathologic stage of multiple organ
dysfunction[3–5]. Hence, a reasonable and effective treatment
schedule set for acute lung injury can stop further
development of illness condition and lower the morbidity
and mortality of multiple organ dysfunction syndrome
(MODS).
The main pathological features of pulmonary contusion
include the bleeding and edema of lung tissue in contusion area
combining with a large number of inﬂammatory cells in-
ﬁltrations. The activation of inﬂammatory reaction and the
release of inﬂammatory mediators in local tissues are the critical
pathological links for causing lung injury. Inhibiting the in-
ﬂammatory reaction is an important objective to treat pulmonary
contusion and prevent MODS[6–8]. Anisodamine, namely, 654-2,
is a kind of alkaloid drug extracted and puriﬁed from Solanaceae
botany, Anisodus tanguticus (Maxim.), which can relieve the
bronchospasm, improve the function of pulmonary exchange
and ventilation, alleviate microcirculatory disturbance, enhance
the effect of microcirculatory blood supply, relieve the local
inﬂammatory reaction of wound tissues and promote the
absorption of inﬂammatory mediators[9–11]. In the following
research, we used anisodamine combining with conventional
scheme to treat acute lung injury.
2. Materials and methods
2.1. Case data
A total of 48 patients with acute pulmonary contusion treated
in our hospital emergency department from April 2011 to
October 2015 were enrolled as the research objects. The
approval was obtained from the hospital ethical committee and
informed consent was obtained from the objects enrolled. All the
patients had positive history of chest trauma and were conﬁrmed
with pulmonary contusion by the CT examination of chest after
admission, and patients with the trauma of other organs or active
bleeding and a history of chronic respiratory disease were
excluded. A total of 48 patients enrolled included 33 male cases
and 15 female cases and their age were 15–68 years with a mean
age of (37.6 ± 5.2) years. The causes of injury included trafﬁc
accident (33 cases), crush injury (7 cases) and fall injury (8
cases).Oxygenation index 239.52 ± 42.29 242.45 ± 39.45
APACHE II score 17.69 ± 2.96 17.14 ± 2.64
BUN (mmol/L) 8.51 ± 0.92 9.14 ± 1.26
Scr (mmol/L) 94.33 ± 14.25 96.18 ± 12.77
ALT (IU/L) 32.85 ± 5.69 34.12 ± 4.86
AST (IU/L) 29.38 ± 4.72 30.52 ± 4.242.2. Grouping methods
The 48 patients enrolled were divided into experimental
group and control group with a method of random number table
and each group included 24 cases. After admission, the patients
of experimental group and control group were actively disposed
and treated at the original injury locations to keep unobstructed
respiratory tract, and ventilator should be offered for the severe
patients to assist breathing. Also the antibiotics were used to
prevent pulmonary infection. Hormone and appropriate volume
of human serum albumin or blood component transfusion were
used as needed. The patients of experimental group received
anisodamine treatment based on the above treatment and the
method was listed as follow: 1.0 mg/kg anisodamine injection
was used for intravenous injection for continuous 3 days (3
times/day).2.3. Evaluation methods of clinical indexes
In the process of treatment, the mechanical ventilation time,
hospital stays in intensive care unit (ICU) and the number of
cases developed into ARDS and MODS of patients in two
groups were observed. Oxygenation indexes of patients were
respectively calculated on Days 1, 2 and 3 after injecting ani-
sodamine. About 5–10 mL peripheral-blood specimens of pa-
tients in two groups were collected. After getting serum
centrifuged, ELISA was used to detect the contents of serum C-
reactive protein (CRP), tumor necrosis factor a (TNF-a), a
interleukin-6 (IL-6), IL-10 and myeloid cells-1 (sTREM-1) on
Day 3 after treatment.
2.4. Statistics process methods
The data were inputted by using SPSS 22.0 software and
measurement data underwent homogeneity test for variance,
which ﬁtted normal distribution were expressed as mean ± SD.
The measurement data of normal distribution between two
groups were analyzed by using t-test. Enumeration data were
expressed by using frequency number and were analyzed by
Chi-square test. Differences were considered statistically sig-
niﬁcant when P < 0.05.
3. Results
3.1. General clinical data
The gender, age, respiratory frequency, oxygenation index,
APACHE II score and the contents of serum creatinine, urea
nitrogen, alanine aminotransferase and aspartate aminotrans-
ferase had no signiﬁcant difference (Table 1).3.2. General conditions of treatment
The mechanical ventilation time and hospital stays in ICU of
patients in experimental group were signiﬁcantly shorter than
those in control group, and the number of cases developed into
ARDS and MODS cases was signiﬁcantly less than those in
control group (Table 2). Oxygenation indexes (294.52 ± 41.26
vs. 257.63 ± 38.52; 357.74 ± 47.74 vs. 279.87 ± 31.46;
396.71 ± 55.12 vs. 279.87 ± 31.46) of patients were respectively
calculated on Days 1, 2 and 3 after treatment, which were
signiﬁcantly higher than those in the control group (Table 2).
Table 2
The general conditions of treatment of patients in two groups.
General condition Experimental
group (n = 24)
Control
group (n = 24)
Mechanical ventilation
time (day)
4.28 ± 0.61* 6.65 ± 0.91
Hospital stays in
ICU (day)
9.52 ± 1.41* 14.57 ± 2.51
ARDS cases 1 (4.17%)* 9 (37.50%)
MODS cases 1 (4.17%)* 7 (29.17%)
Oxygenation indexes
Day 1 after treatment 294.52 ± 41.26* 257.63 ± 38.52
Day 2 after treatment 357.74 ± 47.74* 279.87 ± 31.46
Day 3 after treatment 396.71 ± 55.12* 301.35 ± 40.29
*: P < 0.05 compared with control group.
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On Day 3 after treatment, the contents of serum CRP, TNF-a,
IL-6, IL-8, IL-10 and sTREM-1 of patients in experimental
group were signiﬁcantly lower than those in the control group
(Table 3).Table 3




group (n = 24)
Control
group (n = 24)
CRP (mg/L) 7.94 ± 1.05* 14.49 ± 2.97
TNF-a (ng/L) 264.69 ± 41.58* 417.87 ± 64.51
IL-6 (ng/L) 147.72 ± 21.36* 257.68 ± 41.54
IL-8 (ng/L) 93.68 ± 12.52* 145.62 ± 22.65
IL-10 (ng/L) 205.64 ± 31.56* 336.62 ± 51.38
sTREM-1 (ng/L) 73.32 ± 10.39* 114.45 ± 18.51
*: P < 0.05 compared with control group.4. Discussion
Acute pulmonary contusion is the common concurrent
change after blunt chest trauma, which results in the bleeding
and edema of lung tissue and the activation of inﬂammatory
reaction in contusion area, and further causes the relevant
change of acute lung injury and signiﬁcantly increases the risk of
incidence of ARDS and MODS.
Acute lung injury is the initial factor to cause ARDS and
MODS and also is an important pathologic change of multiple
pathological links throughout multiple organ damage. The
inﬁltration of local injured inﬂammatory cells and the release of
inﬂammatory mediators are the most important pathological
features of acute lung injury and the pathological basis for acute
lung injury developing into ARDS and MODS[12]. Therefore, a
treatment schedule set for the inﬂammatory reaction of acute
lung injury to prevent the activation of inﬂammatory reaction
and the release of inﬂammatory mediators can effectively
delay the progress of disease, prevent the occurrence of ARDS
and MODS and improve the prognosis of disease.
Anisodamine can resist the function of M acetylcholine re-
ceptor and exert the effect of relieving smooth muscle spasm,
improving the function of pulmonary exchange and ventilation,
alleviating microcirculatory disturbance and increasing the
blood supply of microcirculation. Removing the vasospasm of
arteriole and venule system in lesser and systemic circulation is
the main pharmacological effects of anisodamine, which can
transfer the blood in lung into systemic circulation. A large doseof anisodamine can promote the spontaneous vasomotion of
arteriole and venule, which is helpful to dredge microcirculation.
Meanwhile, anisodamine can inhibit the aggregation of blood
platelets and granulocytes and the synthesis of thromboxane A2,
decrease the incidence of thrombus of lesser circulation, stabilize
lysosomal membrane, improve capillary permeability, activate
and dredge microcirculation and accelerate the absorption of
pulmonary edema, which reduces intrapulmonary shunt, en-
hances lung compliance, increases pulmonary ventilation, im-
proves pulmonary exchange and ventilation and elevates oxygen
partial pressure. The relief of states of airways spasm and the
improvement of function of pulmonary exchange and ventilation
can effectively reverse the impairment of lung function caused
by pulmonary contusion, and the improvement of microcircu-
lation can relieve the activation of inﬂammatory reaction and
promote the absorption of local inﬂammatory factors[13–15]. In
recent years, pharmacological research also conﬁrmed that
anisodamine can regulate the expression of aquaporin-1 and
aquaporin-5, enhance the permeability of cytomembrane for
water molecule, accelerate the backﬂow of vascular system and
alleviate the state of pulmonary edema caused by trauma, which
are helpful to the improvement of lung function. In this research,
the vein was injected with anisodamine based on conventional
therapy and according to general condition of treatment, we
observed that the mechanical ventilation time and hospital stays
in ICU of patients in experimental group were signiﬁcantly
shorter than those in control group, and the number of cases
developed into ARDS and MODS was signiﬁcantly less than
those in control group. Oxygenation indexes of patients were
respectively calculated on Days 1, 2 and 3 after treatment, which
were signiﬁcantly higher than those in the control group, which
indicated that treatment with anisodamine can promote the re-
covery of illness condition, reduce the incidence of ARDS and
MODS, and improve the function of pulmonary exchange and
ventilation.
Inﬂammatory reaction is an important pathologic basis of
acute lung injury caused by pulmonary contusion and its process
is mediated by a variety of inﬂammatory mediators[7]. CRP is a
kind of acute phase proteins synthetised and secreted by hepatic
cells. Hepatic cells, which are effected by pro-inﬂammatory
cytokines, such as IL-1b, TNF-a, can massively produce CRP
and secrete into blood circulation. There is a good coincidence
between the content of serum CRP and the degree of body's
inﬂammatory response[16,17]. TNF-a changes the earliest among
inﬂammatory mediators in the process of inﬂammatory
reaction, which participates in inﬂammatory injury of tissues
and the cascade ampliﬁcation of inﬂammatory reaction[18]. The
cytokines IL-6 and IL-8 possess many biological activities,
which participate in the regulations of inﬂammatory reaction and
immune response and enhance the inﬂammatory reaction of
systemic organs caused by acute lung injury. IL-10 is an
important anti-inﬂammatory cytokine in body, which exerts the
inhibiting effect on the activation of mononuclear macrophage
and the synthesis of inﬂammatory mediators. The compensatory
increase of the content of serum IL-10 in the process of acute
lung injury is the self-protective mechanism of body. While,
sTREM-1 is the new-found trigger factor of inﬂammatory re-
action in the recent years, which activates the synthesis and
secretion of many inﬂammatory mediators through the
passageway of TREM-1/DAP12[19]. We analyzed the contents of
inﬂammatory mediators of patients with pulmonary contusion
after treatment and the results showed that on Day 3 after
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and sTREM-1 of patients in experimental group were obviously
lower than those in control group, which showed that anisod-
amine had inhibiting effect on the inﬂammatory reaction of
patients with acute pulmonary contusion and can inhibit the
synthesis and secretion of inﬂammatory mediators in the course
of disease.
In conclusion, anisodamine combining with conventional
therapy can relieve the degree of lung injury caused by acute
pulmonary contusion, improve ventilatory function, lower the
incidence of ARDS and MODS and inhibit the activation of
inﬂammatory reaction and the release of inﬂammatory
mediators.
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